Brazil Metagenomics Market Size & Outlook, 2023-2030
Brazil metagenomics market, 2018-2030 (US$M)
Related Markets
Brazil metagenomics market highlights
- The Brazil metagenomics market generated a revenue of USD 75.1 million in 2023 and is expected to reach USD 191.5 million by 2030.
- The Brazil market is expected to grow at a CAGR of 14.3% from 2024 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2023.
- Sequencing & Data Analytics Services is the most lucrative product segment registering the fastest growth during the forecast period.
Metagenomics market data book summary
| Market revenue in 2023 | USD 75.1 million |
| Market revenue in 2030 | USD 191.5 million |
| Growth rate | 14.3% (CAGR from 2023 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Sequencing & Data Analytics Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Sequencing & Data Analytics Services, Software |
| Key market players worldwide | Bio-Rad Laboratories Inc, Illumina Inc, PerkinElmer, Thermo Fisher Scientific Inc, Novogene, Promega, Qiagen NV, Takara Bio Inc, Oxford Nanopore Technologies PLC, Roche Holding AG |
Other key industry trends
- In terms of revenue, Brazil accounted for 3.7% of the global metagenomics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil metagenomics market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 191.5 million by 2030.
Kits & reagents was the largest segment with a revenue share of 61.52% in 2023. Horizon Databook has segmented the Brazil metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.
The Brazil metagenomics market is expected to continue R&D of molecular test kits using NGS to diagnose brain disorders such as autism through startup companies such as Mendelics and Genius. Furthermore, the presence of a naturally diverse ethnic demographic in the region is expected to boost R&D for NGS-derived diagnostic kits and therapies for certain rare diseases.
These potential avenues for further development of NGS applications are expected to fuel the market growth in this region during the forecast period. The improving infrastructure, expanding sequencing technologies, and increasing interest of global players in this country are also driving the market.
For instance, in November 2019, Veritas Intercontinental signed an agreement with genetic testing lab Genomika, based in Brazil, to offer whole-genome and exome sequencing services in this region.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Metagenomics Market Scope
Metagenomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil metagenomics market size, by product, 2018-2030 (US$M)
Brazil Metagenomics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
